Mazdutide is a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist peptide analogue. In the trial records provided, it is being investigated for the treatment of polycystic ovary syndrome (PCOS) and for its effects on early-stage cognitive impairment in patients with type 2 diabetes.
Investigational. Phase 1/2 and Phase 3 trials identified in the records; not FDA-approved.
Last reviewed October 13, 2026
The calculator takes vial mass, BAC water volume and your target dose, and returns the exact draw on a U-40, U-50 or U-100 insulin syringe. It does the arithmetic; it does not suggest what the dose should be.
Open the reconstitution calculator →